The Navigation Model of Therapy: Why Awareness Changes Everything
November 16, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Beconase AQ, Qnasl, Rivanase
Synonyms :
beclomethasone
Class :
Drugs for asthma and COPD & Corticosteroid (nasal)
Dosage Forms & StrengthsÂ
Aerosol (as dipropionate), solution:Â
80 mcg/actuationÂ
40 mcg/actuation Â
Suspension (as dipropionate), nasal:Â
42 mcg/sprayÂ
Dosage Forms & StrengthsÂ
Aerosol (as dipropionate), solution:Â
80 mcg/actuationÂ
40 mcg/actuationÂ
Suspension (as dipropionate), nasal:Â
42 mcg/sprayÂ
Note: refer to adult dosing for children above 12 yearsÂ
Refer to adult dosingÂ
Corticosteroids may diminish the therapeutic effect of Immune Checkpoint Inhibitors.
Corticosteroids may diminish the therapeutic effect of Immune Checkpoint Inhibitors.
Corticosteroids may diminish the therapeutic effect of Immune Checkpoint Inhibitors.
Corticosteroids may diminish the therapeutic effect of Vaccines
vaccinia immune globulin intravenous (Rx)
Corticosteroids may diminish the therapeutic effect of Vaccines
Corticosteroids may diminish the therapeutic effect of Vaccines
Corticosteroids may diminish the therapeutic effect of Vaccines
Corticosteroids may diminish the therapeutic effect of Vaccines
poliovirus vaccine, live, trivalent
corticosteroids may diminish the therapeutic effect of vaccines
poliovirus vaccine inactivated
corticosteroids may diminish the therapeutic effect of vaccines
corticosteroids may diminish the therapeutic effect of vaccines
smallpox (vaccinia) vaccine, live
corticosteroids may diminish the therapeutic effect of vaccines
corticosteroids may diminish the therapeutic effect of vaccines
corticosteroids may diminish the therapeutic effect of vaccines
corticosteroids may diminish the therapeutic effect of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
may enhance the risk of adverse/toxic effect of rubella- or varicella-containing live vaccines
measles mumps and rubella vaccine, live
may enhance the risk of adverse/toxic effect of rubella- or varicella-containing live vaccines
may enhance the risk of adverse/toxic effect of rubella- or varicella-containing live vaccines
vaccinia immune globulin intravenous (Rx)
may enhance the risk of adverse/toxic effect of rubella- or varicella-containing live vaccines
may enhance the risk of adverse/toxic effect of rubella- or varicella-containing live vaccines
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
measles, mumps, rubella, and varicella vaccine, live (Rx)
it may increase the risk of adverse effects of vaccines
measles mumps and rubella vaccine, live
it may increase the risk of adverse effects of vaccines
it may increase the risk of adverse effects of vaccines
smallpox (vaccinia) vaccine, live
it may increase the risk of adverse effects of vaccines
it may increase the risk of adverse effects of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
it may increase the risk of adverse effects of vaccines
measles mumps and rubella vaccine, live
it may increase the risk of adverse effects of vaccines
it may increase the risk of adverse effects of vaccines
smallpox (vaccinia) vaccine, live
it may increase the risk of adverse effects of vaccines
it may increase the risk of adverse effects of vaccines
may have an increasingly adverse effect when combined with car-t cell immunotherapy
may decrease the therapeutic effect when combined with covid-19 vaccine
respiratory syncytial virus vaccine, adjuvanted
may decrease the therapeutic effect when combined with influenza virus vaccines
respiratory syncytial virus (RSV) vaccine
may decrease the therapeutic effect when combined with influenza virus vaccines
poliovirus vaccine, live, trivalent
may decrease the therapeutic effect when combined with influenza virus vaccines
poliovirus vaccine inactivated
may decrease the therapeutic effect when combined with influenza virus vaccines
corticosteroids: they may decrease the therapeutic effect of vaccines
measles, mumps, rubella, and varicella vaccine, live 
corticosteroids: they may decrease the therapeutic effect of vaccines
measles mumps and rubella vaccine, live
corticosteroids: they may decrease the therapeutic effect of vaccines
corticosteroids: they may decrease the therapeutic effect of vaccines
smallpox (vaccinia) vaccine, live
corticosteroids: they may decrease the therapeutic effect of vaccines
may decrease the therapeutic effect when combined with immune checkpoint inhibitors
may decrease the therapeutic effect when combined with immune checkpoint inhibitors
may decrease the therapeutic effect when combined with immune checkpoint inhibitors
may decrease the therapeutic effect when combined with covid-19 vaccine
respiratory syncytial virus vaccine, adjuvanted
may decrease the therapeutic effect when combined with influenza virus vaccines
respiratory syncytial virus (RSV) vaccine
may decrease the therapeutic effect when combined with influenza virus vaccines
may decrease the therapeutic effect when combined with influenza virus vaccines
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
respiratory syncytial virus vaccine, adjuvanted
may decrease the therapeutic effect when combined with influenza virus vaccines
respiratory syncytial virus (RSV) vaccine
may decrease the therapeutic effect when combined with influenza virus vaccines
poliovirus vaccine, live, trivalent
may decrease the therapeutic effect when combined with influenza virus vaccines
poliovirus vaccine inactivated
may decrease the therapeutic effect when combined with influenza virus vaccines
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
choline magnesium trisalicylate
salicylates may increase the adverse effect of corticosteroids
corticosteroids may enhance the immunosuppressive effect of abrocitinib
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
may increase the immunosuppressive effects of corticosteroids
may increase the immunosuppressive effect
may increase the toxic effect
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may increase the tacrolimus immunosuppressive effect
may have an increased immunosuppressive effect when combined with upadacitinib
may decrease the therapeutic effect of hyaluronidase
may decrease the therapeutic effect of hyaluronidase
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
may diminish the bioavailability of Antacids
may diminish the bioavailability of Antacids
may diminish the bioavailability of Antacids
aluminum hydroxide/magnesium carbonateÂ
may decrease the bioavailability of antacids
aluminum hydroxide/magnesium carbonateÂ
may decrease the bioavailability of antacids
may diminish the antineoplastic effect when combined
may decrease the diagnostic effect when combined with metyrapone
may have an increased immunosuppressive effect when combined with abrocitinib
may have an increased immunosuppressive effect when combined with baricitinib
may decrease the diagnostic effect when combined with coccidioides skin test
may decrease the therapeutic effect when combined with covid-19 vaccine
may have an increased immunosuppressive effect when combined with corticosteroids
may have an increased anticoagulant effect when combined with desirudin
may have an increased immunosuppressive effect when combined with corticosteroids
may decrease the therapeutic effect when combined with influenza virus vaccines
may have an increased immunosuppressive effect when combined with leflunomide
sipuleucel-T: they may decrease the therapeutic effect of corticosteroids
sipuleucel-T: they may decrease the therapeutic effect of corticosteroids
sipuleucel-T: they may decrease the therapeutic effect of corticosteroids
may diminish the bioavailability when combined with corticosteroids
may diminish the bioavailability when combined with corticosteroids
may decrease the therapeutic effect of each other when combined
may decrease the therapeutic effect of each other when combined
may decrease the therapeutic effect of each other when combined
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
may have an increased adverse neuromuscular effect when combined with corticosteroids
may increase the immunosuppressive effects of corticosteroids
may increase the immunosuppressive effects of corticosteroids
may increase the immunosuppressive effects of corticosteroids
may increase the immunosuppressive effects of corticosteroids
may increase the immunosuppressive effects of corticosteroids
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect of immunosuppressants
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
corticosteroids may diminish the antineoplastic effect of Aldesleukin
measles, mumps, rubella and varicella vaccine, liveÂ
may increase the toxic effects of varicella virus containing vaccine
they enhance the toxicity of rubella or varicella-containing live vaccines
they enhance the toxicity of rubella or varicella-containing live vaccines
may diminish the anti-neoplastic activity
may diminish the diagnostic effect of macimorelin
may increase the hyponatremic effect of corticosteroids
may decrease the antineoplastic effect when combined with aldesleukin
may have an increasingly adverse effect when combined with talimogene laherparepvec
may decrease the antineoplastic effect when combined with aldesleukin
may have an increased hyponatremic effect when combined with desmopressin
may enhance the serum concentration when combined
may enhance the serum concentration when combined
may have an increasingly adverse effect when combined with BCG products
may increase the tachycardic effect of Beta2-Agonists
may increase the hyponatremic effect when combined
may have an increased immunosuppressive effect when combined with cladribine
may have an increasingly adverse effect when combined with dengue vaccine
may decrease the diagnostic effect when combined with macimorelin
may decrease the therapeutic effect when combined with corticosteroids
may have an increasingly adverse effect when combined with nadofaragene firadenovec
may have an increased immunosuppressive effect when combined with natalizumab
may have an increased immunosuppressive effect when combined with corticosteroids
indium In-111 capromab pendetideÂ
may decrease the diagnostic effect when combined
indium In-111 capromab pendetideÂ
may decrease the diagnostic effect when combined
indium In-111 capromab pendetideÂ
may decrease the diagnostic effect when combined
etonogestrel/ethinyl estradiolÂ
may increase the thrombogenic effect of Hormonal Contraceptives
It may decrease the antineoplastic effect when combined with Corticosteroids
It may decrease the antineoplastic effect when combined with Corticosteroids
may enhance the serum concentration when combined with corticosteroids
may enhance the serum concentration when combined with corticosteroids
corticosteroids May enhance the adverse/toxic effect of quinolones.
corticosteroids May enhance the adverse/toxic effect of quinolones.
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may diminish the therapeutic effect of immune Checkpoint inhibitors
may diminish the therapeutic effect of immune Checkpoint inhibitors
may diminish the therapeutic effect of immune Checkpoint inhibitors
may increase the hypokalemic effect of thiazide diuretics
may increase the hypokalemic effect of thiazide diuretics
may increase the hypokalemic effect of thiazide diuretics
may increase the hypokalemic effect of thiazide diuretics
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of quinolones
may enhance the adverse effect of quinolones
may enhance the adverse effect of quinolones
may enhance the adverse effect of quinolones
may enhance the adverse effect of quinolones
may enhance the adverse effect of quinolones
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the serum concentration
may increase the serum concentration
bazedoxifene/conjugated estrogens
may increase the serum concentration
synthetic conjugated estrogens, a
may increase the serum concentration
synthetic conjugated estrogens, b
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
bazedoxifene/conjugated estrogens
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
bazedoxifene/conjugated estrogens
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
They may diminish the absorption when combined with bile acid sequestrants
They may diminish the absorption when combined with bile acid sequestrants
may decrease the therapeutic effect when combined with agents of urea cycle disorder
corticosteroids: they may increase the hypokalemic effect when combined with thiazides
corticosteroids: they may increase the hypokalemic effect when combined with thiazides
corticosteroids: they may increase the hypokalemic effect when combined with thiazides
corticosteroids: they may increase the hypokalemic effect when combined with thiazides
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
relugolix/​estradiol/​norethindrone
may have an increased fluid-retaining effect when combined with androgens
relugolix/estradiol/norethindrone
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may diminish the absorption when combined with corticosteroids
It may enhance the risk of adverse effects when combined with Respiratory tract infections
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increased hypokalemic effect when combined with amphotericin b
may increase the hypokalemic effect of loop diuretics
may increase the hypokalemic effect of loop diuretics
may increase the hypokalemic effect of loop diuretics
may increase the hypokalemic effect of thiazide diuretics
may increase the hypokalemic effect of thiazide diuretics
corticosteroids: they may increase the anticoagulant effect of anticoagulants
corticosteroids: they may increase the anticoagulant effect of anticoagulants
corticosteroids: they may increase the anticoagulant effect of anticoagulants
corticosteroids: they may increase the anticoagulant effect of anticoagulants
corticosteroids: they may increase the anticoagulant effect of anticoagulants
corticosteroids j3: they may increase the anticoagulant effect of anticoagulants
corticosteroids j3: they may increase the anticoagulant effect of anticoagulants
corticosteroids j3: they may increase the anticoagulant effect of anticoagulants
corticosteroids j3: they may increase the anticoagulant effect of anticoagulants
corticosteroids j3: they may increase the anticoagulant effect of anticoagulants
corticosteroids j4: they may increase the anticoagulant effect of anticoagulants
corticosteroids j4: they may increase the anticoagulant effect of anticoagulants
corticosteroids j4: they may increase the anticoagulant effect of anticoagulants
corticosteroids j4: they may increase the anticoagulant effect of anticoagulants
corticosteroids j4: they may increase the anticoagulant effect of anticoagulants
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
sodium picosulfate, citric acid, and magnesium oxide
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
sodium picosulfate, citric acid, and magnesium oxide
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
sodium picosulfate, citric acid, and magnesium oxide
may diminish the effect of each other when combined
may increase the hypokalemic effect when combined with thiazide diuretics
may increase the hypokalemic effect when combined with thiazide diuretics
may increase the hypokalemic effect when combined with thiazide diuretics
may increase the hypokalemic effect when combined with thiazide diuretics
may increase the hypokalemic effect when combined with thiazide diuretics
may have an increasingly adverse effect when combined with NSAIDs
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
relugolix/​estradiol/​norethindrone
may have an increased fluid-retaining effect when combined with androgens
relugolix/estradiol/norethindrone
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with agents of urea cycle disorder
may enhance the serum concentration of CYP3A4 inhibitor
may enhance the serum concentration of CYP3A4 inhibitor
may enhance the serum concentration of CYP3A4 inhibitor
may enhance the serum concentration of CYP3A4 inhibitor
may enhance the serum concentration of CYP3A4 inhibitor
relugolix/estradiol/norethindrone
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
spironolactone and hydrochlorothiazide
may increase the hypokalemic effect when combined with diuretics
may increase the hypokalemic effect when combined with diuretics
may increase the hypokalemic effect when combined with diuretics
may increase the hypokalemic effect when combined with diuretics
may increase the hypokalemic effect when combined with diuretics
may have an increasingly adverse effect when combined with NSAIDs
it may increase the risk of adverse effects of acetylcholinesterase inhibitors 
it may increase the risk of adverse effects of acetylcholinesterase inhibitors
it may enhance the risk of adverse effects of Acetylcholinesterase Inhibitors
it may enhance the risk of adverse effects of Acetylcholinesterase Inhibitors
corticosteroids may increase the risk of adverse effects of acetylcholinesterase Inhibitors
corticosteroids may increase the risk of adverse effects of acetylcholinesterase Inhibitors
corticosteroids may increase the risk of adverse effects of acetylcholinesterase Inhibitors
corticosteroids may increase the risk of adverse effects of acetylcholinesterase Inhibitors
corticosteroids may increase the risk of adverse effects of acetylcholinesterase Inhibitors
corticosteroids may increase the fluid-retaining effect of androgens
corticosteroids may increase the fluid-retaining effect of androgens
corticosteroids may increase the fluid-retaining effect of androgens
corticosteroids may increase the fluid-retaining effect of androgens
corticosteroids may increase the fluid-retaining effect of androgens
bile Acid Sequestrants May reduce the absorption of corticosteroids
Corticosteroids may reduce the therapeutic effect of Brincidofovir
corticosteroids (Systemic) may reduce the therapeutic effect of calcitriol
corticosteroids may enhance the immunosuppressive effect of cladribine
Corticosteroids may diminish the therapeutic effect of Growth Hormone Analogs
Corticosteroids may diminish the therapeutic effect of Growth Hormone Analogs
Corticosteroids may diminish the therapeutic effect of Growth Hormone Analogs
corticosteroids may enhance the adverse/toxic effect of NSAIDs
corticosteroids may enhance the adverse/toxic effect of NSAIDs
corticosteroids may enhance the adverse/toxic effect of NSAIDs
corticosteroids may enhance the adverse/toxic effect of NSAIDs
corticosteroids may enhance the adverse/toxic effect of NSAIDs
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
Corticosteroids may enhance the adverse/toxic effect of nonsteroidal Anti-Inflammatory agents
Corticosteroids may enhance the adverse/toxic effect of nonsteroidal Anti-Inflammatory agents
corticosteroids may enhance the hypokalemic effect of Thiazide and thiazide-Like diuretics
corticosteroids may enhance the hypokalemic effect of Thiazide and thiazide-Like diuretics
corticosteroids may enhance the hypokalemic effect of Thiazide and thiazide-Like diuretics
corticosteroids may enhance the hypokalemic effect of Thiazide and thiazide-Like diuretics
may increase the adverse/toxic effect of dengue vaccine
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may increase the fluid retaining effect
may increase the toxic effects
may increase the therapeutic effect
may increase the toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may increase the toxic effect of non-steroidal anti-inflammatory drugs
may increase the toxic effect
choline magnesium trisalicylate
may enhance the adverse effect of corticosteroids
may enhance the serum concentration of nirmatrelvir and ritonavir
may increase the toxic effect of Nonsteroidal Anti-Inflammatory Agents
may reduce the rate of absorption of corticosteroids
may reduce the rate of absorption of corticosteroids
may reduce the rate of absorption of corticosteroids
choline magnesium trisalicylate
may enhance the adverse effect of corticosteroids
choline magnesium trisalicylate
may enhance the adverse effect of corticosteroids
choline magnesium trisalicylate
may enhance the adverse effect of corticosteroids
may enhance the toxic effect of salicylates
may have a decreased diagnostic effect when combined with cosyntropin
may increase the hypokalemic effect of amphotericin
may increase the hypokalemic effect of amphotericin
may increase the hypokalemic effect of amphotericin
may have an increased hypokalemic effect when combined with amphotericin B
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
estrogens esterified/methyltestosterone            Â
may enhance the serum concentration of estrogen derivatives
estrogens esterified/methyltestosterone            Â
may enhance the serum concentration of estrogen derivatives
drospirenone/ethinyl estradiol/levomefolateÂ
may enhance the serum concentration of Estrogen Derivatives
They may diminish the absorption when combined with bile acid sequestrants
may decrease the diagnostic effect when combined with cosyntropin
may enhance the serum concentration when combined with corticosteroids
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
ciprofloxacin inhaled (Pending FDA approval)Â
May increase the toxic effect of Quinolones
ciprofloxacin inhaled (Pending FDA approval)Â
May increase the toxic effect of Quinolones
may increase the toxic effect of Acetylcholinesterase Inhibitors
may increase the toxic effect of Acetylcholinesterase Inhibitors
may increase the toxic effect of Acetylcholinesterase Inhibitors
may have an increased hypokalemic effect when combined with amphotericin b
antithymocyte globulin equineÂ
may have an increasingly adverse effect when combined with antithymocyte globulin
may decrease the therapeutic effect when combined with brincidofovir
may decrease the therapeutic effect when combined with calcitriol
may decrease the therapeutic effect when combined with corticorelin
may have an increasingly adverse effect when combined with deferasirox
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
bazedoxifene/conjugated estrogens
may enhance the concentration of serum when combined with corticosteroids
synthetic conjugated estrogens, a
may enhance the concentration of serum when combined with corticosteroids
synthetic conjugated estrogens, b
may enhance the concentration of serum when combined with corticosteroids
cyproterone and ethinyl estradiolÂ
may enhance the serum concentration of Estrogen Derivatives
cyproterone and ethinyl estradiolÂ
may enhance the serum concentration of Estrogen Derivatives
etonogestrel/ethinyl estradiolÂ
may increase the serum concentration of estrogen derivatives
may enhance the serum concentration of each other when combined
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may enhance the serum concentration when combined with corticosteroids
may enhance the serum concentration when combined with corticosteroids
It may enhance the risk of adverse effects when combined with Anticoagulants
It may enhance the risk of adverse effects when combined with Anticoagulants
It may enhance the risk of adverse effects when combined with Anticoagulants
It may enhance the risk of adverse effects when combined with Anticoagulants
It may enhance the risk of adverse effects when combined with Anticoagulants
may decrease the therapeutic effect when combined with agents of urea cycle disorder
sodium bicarbonate: they may decrease the therapeutic effect of corticosteroids A1
sodium bicarbonate: they may decrease the therapeutic effect of corticosteroids J3
sodium bicarbonate: they may decrease the therapeutic effect of corticosteroids J4
sodium phenylbutyrate: they may decrease the therapeutic effect of corticosteroids A1
sodium phenylbutyrate: they may decrease the therapeutic effect of corticosteroids J3
probenecid: they may decrease the therapeutic effect of corticosteroids A1
probenecid: they may decrease the therapeutic effect of corticosteroids J3
valproic acid: they may decrease the therapeutic effect of corticosteroids A1
valproic acid: they may decrease the therapeutic effect of corticosteroids J3
may decrease the anti-neoplastic effect of each other when combined
may decrease the anti-neoplastic effect of each other when combined
may decrease the anti-neoplastic effect of each other when combined
betamethasone + salicylic acidÂ
may enhance the serum concentration of corticosteroids
abiraterone acetate and niraparibÂ
may decrease the therapeutic effect of immunosuppressive Agents
may increase the hypokalemic effect when combined with thiazide diuretics
may increase the hypokalemic effect when combined with thiazide diuretics
may increase the hypokalemic effect when combined with thiazide diuretics
may increase the hypokalemic effect when combined with thiazide diuretics
may increase the hypokalemic effect when combined with thiazide diuretics
may have an increased immunosuppressive effect when combined with corticosteroids
may have an increased immunosuppressive effect when combined with corticosteroids
may have an increased immunosuppressive effect when combined with corticosteroids
may have an increased immunosuppressive effect when combined with corticosteroids
may have an increased adverse effect when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
bazedoxifene/conjugated estrogens
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
bazedoxifene/conjugated estrogens
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
Frequency defined:Â Â Â
>10%Â
HeadacheÂ
Epistaxis  Â
1% to 10%Â
Localized erythemaÂ
FeverÂ
Abdominal stressÂ
Weight gainÂ
DiarrheaÂ
DizzinessÂ
Dry noseÂ
Blood in the nasal mucosa Â
<1%Â
Esophageal candidiasis Â
Nasal candidiasisÂ
Pharyngeal candidiasisÂ
Â
Pregnancy consideration: limited use in usual doses may be acceptable during pregnancy.Â
Lactation: Beclomethasone excretion in breast milk is not known. Â
Pregnancy category:Â
Patient information leafletÂ
Generic Name: BeclomethasoneÂ
Pronounced: Bec-lo-me-ta-zonÂ
Â
Why do we use beclomethasone?Â
Beclomethasone is a nasal corticosteroid. It is used to treat allergic rhinitis and upper respiratory allergies.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
